Diagnosis

Displaying 1 - 10 of 181

Bloom2 cardiac stimulator receives FDA 510(k) clearance

Bloom2 cardiac stimulator receives FDA 510(k) clearance
Fischer Medical has announced that the Bloom2 cardiac electrophysiology stimulator device has received FDA 510(k) clearance. The Bloom2 stimulator is a fundamental component of nearly all electrophysiology (EP) procedures to diagnose and treat cardiac rhythm disorders. The release of the digital version of the Bloom gives electrophysiologists and EP staff members a modern user interface, eliminates tedious dropdown menus and retains the tactile feel of the original Bloom.
18th April 2018

Using AI to detect heart disease

Using AI to detect heart disease
Heart disease is the leading cause of death for both men and women, according to the Centers for Disease Control and Prevention (CDC). In the U.S., one in every four deaths is a result of heart disease, which includes a range of conditions from arrhythmias, or abnormal heart rhythms, to defects, as well as blood vessel diseases, more commonly known as cardiovascular diseases.
18th April 2018

An augmented reality microscope for cancer detection

An augmented reality microscope for cancer detection
Applications of deep learning to medical disciplines including ophthalmology, dermatology, radiology, and pathology have recently shown great promise to increase both the accuracy and availability of high-quality healthcare to patients around the world. Google has also published results showing that a convolutional neural network is able to detect breast cancer metastases in lymph nodes at a level of accuracy comparable to a trained pathologist.
18th April 2018


Device for detection of diabetic retinopathy receives FDA approval

Device for detection of diabetic retinopathy receives FDA approval
  IDx has announced that the FDA has granted the company’s De Novo request to market IDx-DR, an AI-based diagnostic system for the autonomous detection of diabetic retinopathy, a leading cause of blindness. IDx-DR is the first autonomous, AI-based diagnostic system authorised for commercialisation by the FDA.
13th April 2018

Light technique could help diagnose illness

Light technique could help diagnose illness
A method of using light to scan the human body, developed by researchers at the University of St Andrews, could result in less intrusive and more effective diagnosis for patients. The work is the result of a collaboration between researchers from the Schools of Physics and Astronomy, Biology, Medicine and the Scottish Oceans Institute at the University. The new technique allows the light to be shaped so it can reach greater depths within biological tissue enabling high quality 3D images to be acquired.
11th April 2018

Hybrid nano-probe can detect live cancer cells

Hybrid nano-probe can detect live cancer cells
Fabien Pinaud’s big vision for treating cancer homes in on the smallest of targets. Along with a team of scientists, he created a new hybrid nano-probe that could lead to noninvasive detection and treatment of the disease at the level of a single cell. Pinaud, assistant professor of biological sciences, chemistry and physics and astronomy at USC Dornsife, developed a method for amplifying a biochemical signal on the surface of cancer cells.
5th April 2018

Mobile application can detect atrial fibrillation

Mobile application can detect atrial fibrillation
An application developed at the University of Turku, can detect atrial fibrillation that causes strokes. Atrial fibrillation can be detected with the mobile phone application without any extra equipment. The mobile application can save lives all over the world as timely diagnosis of atrial fibrillation is crucial for effective stroke prevention. ​The joint research project of the University of Turku and the Heart Centre of the Turku University Hospital studied three hundred patients with heart problems, half of whom had atrial fibrillation.
5th April 2018

3D-printed anatomical models receive FDA clearance

3D-printed anatomical models receive FDA clearance
Materialise NV has received FDA clearance for software intended for 3D printing anatomical models for diagnostic use. Leading hospitals are adopting integrated 3D printing services as part of their medical practices as they recognise the added value it brings to personalised patient care. Materialise brings nearly three decades of experience in developing medical solutions that help researchers, engineers and clinicians achieve the desired patient outcomes.
4th April 2018

ConfidenHT System receives CE Mark

ConfidenHT System receives CE Mark
Pythagoras Medical, a cutting edge medical device company established by Rainbow Medical, has announced that its ConfidenHT System has received a European CE Mark. ConfidenHT is a novel system for patients with resistant hypertension, which improves the efficacy of renal denervation (RDN) procedures. ConfidenHT provides real-time guidance to physicians by identifying ablation "hot spots", verifying ablation effectiveness and identifying non-responder patients.
29th March 2018

Brain scanner allows patients to move freely

Brain scanner allows patients to move freely
A new generation of brain scanner, that can be worn like a helmet allowing patients to move naturally whilst being scanned, has been developed by researchers at the Sir Peter Mansfield Imaging Centre, University of Nottingham and the Wellcome Centre for Human Neuroimaging, UCL. It is part of a five-year Wellcome funded project which has the potential to revolutionise the world of human brain imaging.
26th March 2018


Diagnosis documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry